Marble Harbor Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Sell |
445,070
-878
| -0.2% | -$23.4K | 1.35% | 25 |
|
|
2025
Q4 | $11.1M | Buy |
445,948
+52,827
| +13% | +$1.33M | 1.19% | 28 |
|
|
2025
Q3 | $10M | Buy |
393,121
+26,200
| +7% | +$647K | 1.05% | 32 |
|
|
2025
Q2 | $8.89M | Buy |
366,921
+15,447
| +4% | +$360K | 0.97% | 32 |
|
|
2025
Q1 | $8.91M | Sell |
351,474
-5,335
| -1% | -$140K | 1% | 32 |
|
|
2024
Q4 | $9.47M | Buy |
356,809
+18,254
| +5% | +$495K | 1.04% | 30 |
|
|
2024
Q3 | $9.8M | Sell |
338,555
-3,916
| -1% | -$114K | 1.07% | 28 |
|
|
2024
Q2 | $9.58M | Sell |
342,471
-9,439
| -3% | -$260K | 1.13% | 26 |
|
|
2024
Q1 | $9.77M | Sell |
351,910
-3,584
| -1% | -$99.5K | 1.13% | 28 |
|
|
2023
Q4 | $10.2M | Buy |
355,494
+3,625
| +1% | +$110K | 1.26% | 23 |
|
|
2023
Q3 | $11.7M | Buy |
351,869
+1,492
| +0.4% | +$52.8K | 1.53% | 20 |
|
|
2023
Q2 | $12.9M | Buy |
350,377
+1,112
| +0.3% | +$43.3K | 1.62% | 18 |
|
|
2023
Q1 | $14.3M | Buy |
349,265
+1,860
| +0.5% | +$80.3K | 1.84% | 17 |
|
|
2022
Q4 | $17.8M | Buy |
347,405
+5,399
| +2% | +$259K | 2.4% | 11 |
|
|
2022
Q3 | $15M | Buy |
342,006
+348
| +0.1% | +$16.9K | 2.28% | 11 |
|
|
2022
Q2 | $17.9M | Buy |
341,658
+4,297
| +1% | +$219K | 2.73% | 8 |
|
|
2022
Q1 | $17.5M | Sell |
337,361
-2,805
| -0.8% | -$146K | 2.17% | 14 |
|
|
2021
Q4 | $20.1M | Buy |
340,166
+12,871
| +4% | +$638K | 2.34% | 12 |
|
|
2021
Q3 | $14.1M | Sell |
327,295
-22,136
| -6% | -$981K | 1.9% | 17 |
|
|
2021
Q2 | $13.7M | Sell |
349,431
-1,157
| -0.3% | -$45K | 1.77% | 17 |
|
|
2021
Q1 | $12.7M | Buy |
350,588
+12,059
| +4% | +$428K | 1.74% | 19 |
|
|
2020
Q4 | $12.5M | Sell |
338,529
-18,014
| -5% | -$661K | 1.83% | 17 |
|
|
2020
Q3 | $12.4M | Sell |
356,543
-211
| -0.1% | -$7.4K | 2.03% | 18 |
|
|
2020
Q2 | $11.1M | Sell |
356,754
-19,254
| -5% | -$654K | 1.92% | 19 |
|
|
2020
Q1 | $11.6M | Buy |
376,008
+20,402
| +6% | +$695K | 2.29% | 16 |
|
|
2019
Q4 | $13.2M | Buy |
355,606
+7,690
| +2% | +$274K | 2.09% | 14 |
|
|
2019
Q3 | $11.9M | Sell |
347,916
-2,421
| -0.7% | -$88K | 2.11% | 16 |
|
|
2019
Q2 | $14.4M | Buy |
350,337
+738
| +0.2% | +$29.3K | 2.49% | 10 |
|
|
2019
Q1 | $14.1M | Sell |
349,599
-1,476
| -0.4% | -$59.1K | 2.51% | 11 |
|
|
2018
Q4 | $14.5M | Sell |
351,075
-342
| -0.1% | -$14.2K | 2.9% | 10 |
|
|
2018
Q3 | $14.7M | Sell |
351,417
-821
| -0.2% | -$31.6K | 2.61% | 11 |
|
|
2018
Q2 | $12.1M | Sell |
352,238
-507
| -0.1% | -$17.3K | 2.31% | 14 |
|
|
2018
Q1 | $11.9M | Buy |
352,745
+5,175
| +1% | +$178K | 2.35% | 11 |
|
|
2017
Q4 | $11.9M | Sell |
347,570
-211
| -0.1% | -$7.2K | 2.32% | 15 |
|
|
2017
Q3 | $11.8M | Sell |
347,781
-9,617
| -3% | -$309K | 2.4% | 14 |
|
|
2017
Q2 | $11.4M | Sell |
357,398
-2,226
| -0.6% | -$70.2K | 2.47% | 15 |
|
|
2017
Q1 | $11.7M | Sell |
359,624
-6,666
| -2% | -$210K | 2.55% | 12 |
|
|
2016
Q4 | $11.3M | Sell |
366,290
-14,453
| -4% | -$441K | 2.54% | 12 |
|
|
2016
Q3 | $12.2M | Sell |
380,743
-896
| -0.2% | -$30K | 2.88% | 10 |
|
|
2016
Q2 | $12.7M | Sell |
381,639
-7,229
| -2% | -$231K | 3.09% | 7 |
|
|
2016
Q1 | $10.9M | Buy |
388,868
+353
| +0.1% | +$10.1K | 2.7% | 10 |
|
|
2015
Q4 | $11.9M | Sell |
388,515
-7,931
| -2% | -$250K | 3.17% | 6 |
|
|
2015
Q3 | $11.8M | Sell |
396,446
-316
| -0.1% | -$10.1K | 3.25% | 4 |
|
|
2015
Q2 | $12.6M | Sell |
396,762
-2,962
| -0.7% | -$96.5K | 3.22% | 5 |
|
|
2015
Q1 | $13.2M | Sell |
399,724
-15,155
| -4% | -$482K | 3.31% | 5 |
|
|
2014
Q4 | $12.3M | Sell |
414,879
-975
| -0.2% | -$28K | 2.79% | 8 |
|
|
2014
Q3 | $11.7M | Buy |
415,854
+199
| +0% | +$5.58K | 2.82% | 7 |
|
|
2014
Q2 | $11.7M | Sell |
415,655
-866
| -0.2% | -$24.7K | 2.77% | 8 |
|
|
2014
Q1 | $12.7M | Sell |
416,521
-1,410
| -0.3% | -$42K | 3.29% | 4 |
|
|
2013
Q4 | $12.1M | Sell |
417,931
-422
| -0.1% | -$12.3K | 3.21% | 5 |
|
|
2013
Q3 | $11.4M | Sell |
418,353
-5,561
| -1% | -$151K | 3.25% | 4 |
|
|
2013
Q2 | $11.3M | Buy |
+423,914
| New | +$11.7M | 3.37% | 4 |
|
Other funds holding PFE
VCM
VPM
Marble Harbor Investment Counsel's PFE Position: Q1 2026 in Review
Marble Harbor Investment Counsel reduced its Pfizer (PFE) stake by 0.2% in Q1 2026, selling an estimated $23.4K and leaving 445,070 shares worth $12.5M. The position accounts for 1.35% of the portfolio, ranked #25.
Marble Harbor Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Marble Harbor Investment Counsel held 445,070 shares of Pfizer worth $12.5M as of Q1 2026.
- Marble Harbor Investment Counsel sold 878 Pfizer shares in Q1 2026, an estimated $23.4K.
- Pfizer made up 1.35% of Marble Harbor Investment Counsel's portfolio in Q1 2026, its #25 holding.
- Marble Harbor Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Marble Harbor Investment Counsel's Pfizer position peaked at $20.1M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Marble Harbor Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.